David Plouffe, a board member of Oscar Health, Inc., has reported the acquisition of 641 deferred stock units, according to a recent SEC filing. This acquisition increases his total holdings to 8,176 units. The move underscores the commitment of board members to the company's long-term success.
The filing, dated October 13, 2026, reveals that Plouffe made the acquisition on October 8, 2026, at a price of $33.10 per share. This decision to receive deferred stock units in lieu of cash retainer payments indicates a strategic approach to align board member interests with the company’s performance.
Background
Oscar Health, Inc. is a health insurance company that focuses on providing health insurance plans to individuals and families. The company operates under the SIC classification of Hospital & Medical Service Plans. Oscar Health trades on the stock market under the ticker symbol OSCR and is based in New York, NY.
What the Filing Says
The SEC filing states, "The Reporting Person elected... to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors." This indicates that Plouffe is opting for equity compensation, which is often viewed as a way to enhance alignment with shareholder interests.
Impact
This acquisition may influence other board members and executives in the hospital and medical service plans industry to consider similar compensation structures. By opting for deferred stock units, Plouffe is signaling confidence in Oscar Health’s future performance, which could encourage other leaders in the industry to adopt comparable strategies to retain top talent.
What's Next
The filing does not say what happens next.